Nature Medicine

Journal Abbreviation: NAT MED
ISSN: 1078-8956
eISSN: 1546-170X
Publisher: Nature Publishing Group

Publications (56)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases (2026) Düsing C, Györfi AH, Stütz AN, Lahu LM, Deicher FS, Li YN, Bruch PM, et al. Journal article Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases (2026) Becilli M, Metzler M, Bracaglia C, Nicolai R, Krickau T, Del Bufalo F, Rosignoli C, et al. Journal article Polygenic prediction of body mass index and obesity through the life course and across ancestries (2025) Smit RA, Wade KH, Hui Q, Arias JD, Yin X, Christiansen MR, Yengo L, et al. Journal article BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial (2025) McInnes IB, Coates LC, Mease PJ, Ogdie A, Kavanaugh A, Eder L, Schett G, et al. Journal article Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial (2025) Cardoso F, O’Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum A prognostic neural epigenetic signature in high-grade glioma (2024) Drexler R, Khatri R, Sauvigny T, Mohme M, Maire CL, Ryba A, Zghaibeh Y, et al. Journal article Bispecific T cell engager therapy for refractory rheumatoid arthritis (2024) Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, et al. Journal article